Glucose transporters in diabetic nephropathy
- PMID: 15717166
- DOI: 10.1007/s00467-004-1748-x
Glucose transporters in diabetic nephropathy
Abstract
Changes in glucose transporter expression in glomerular cells occur early in diabetes. These changes, especially the GLUT1 increase in mesangial cells, appear to play a pathogenic role in the development of ECM expansion and perhaps other features of diabetic nephropathy. In addition, it appears that at least some diabetic patients may be predisposed to nephropathy because of polymorphisms in their GLUT1 genes. GLUT1 overexpression leads to increased glucose metabolic flux which in turn triggers the polyol pathway and activation of PKC alpha and B1. Activation of these PKC isoforms can lead directly to AP-1 induced increases in fibronectin expression and ECM accumulation. Other, more novel effects of GLUT1 on cellular hypertrophy and injury could also promote changes of diabetic nephropathy. Strategies to prevent GLUT1 overexpression could ameliorate or prevent the progression of diabetic nephropathy.
Similar articles
-
[The role of cellular glucose transporters in pathogenesis of diabetic nephropathy].Przegl Lek. 1999;56(12):793-9. Przegl Lek. 1999. PMID: 10789192 Review. Polish.
-
Glucose transporters of the glomerulus and the implications for diabetic nephropathy.Kidney Int Suppl. 1997 Sep;60:S91-9. Kidney Int Suppl. 1997. PMID: 9285909 Review.
-
Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.Am J Physiol Renal Physiol. 2010 Jul;299(1):F99-F111. doi: 10.1152/ajprenal.00466.2009. Epub 2010 Apr 7. Am J Physiol Renal Physiol. 2010. PMID: 20375117 Free PMC article.
-
Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro.Am J Physiol. 1999 Jul;277(1):F97-104. doi: 10.1152/ajprenal.1999.277.1.F97. Am J Physiol. 1999. PMID: 10409302
-
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.Diabetes. 1997 Jun;46(6):1030-9. doi: 10.2337/diab.46.6.1030. Diabetes. 1997. PMID: 9166676
Cited by
-
GLUT1 enhances mTOR activity independently of TSC2 and AMPK.Am J Physiol Renal Physiol. 2011 Sep;301(3):F588-96. doi: 10.1152/ajprenal.00472.2010. Epub 2011 May 25. Am J Physiol Renal Physiol. 2011. PMID: 21613414 Free PMC article.
-
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.Diabetes. 2009 Feb;58(2):469-77. doi: 10.2337/db08-1328. Epub 2008 Nov 18. Diabetes. 2009. PMID: 19017763 Free PMC article.
-
Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.Mol Biol Rep. 2012 Aug;39(8):8551-8. doi: 10.1007/s11033-012-1711-z. Epub 2012 Jun 17. Mol Biol Rep. 2012. PMID: 22707195 Review.
-
Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.Am J Physiol Renal Physiol. 2010 Jul;299(1):F91-8. doi: 10.1152/ajprenal.00021.2010. Epub 2010 Apr 7. Am J Physiol Renal Physiol. 2010. PMID: 20375116 Free PMC article.
-
Human Glucose Transporters in Renal Glucose Homeostasis.Int J Mol Sci. 2021 Dec 16;22(24):13522. doi: 10.3390/ijms222413522. Int J Mol Sci. 2021. PMID: 34948317 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous